A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Milton S. Hershey Medical Center
Eli Lilly and Company
Eli Lilly and Company
UNICANCER
Mayo Clinic
Yonsei University
Taiho Pharmaceutical Co., Ltd.
Grupo Espanol de Investigacion en Sarcomas
Italian Sarcoma Group
Blokhin's Russian Cancer Research Center
Emory University
M.D. Anderson Cancer Center
Stanford University
Sierra Oncology LLC - a GSK company
Children's Oncology Group
Innovent Biologics (Suzhou) Co. Ltd.
Roswell Park Cancer Institute
Peking University People's Hospital
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Eleison Pharmaceuticals LLC.
Peking University People's Hospital
Masonic Cancer Center, University of Minnesota
University of Miami
Alliance for Clinical Trials in Oncology
GOG Foundation
Memorial Sloan Kettering Cancer Center
NYU Langone Health
City of Hope Medical Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
University of Chicago
GOG Foundation
Memorial Sloan Kettering Cancer Center
GOG Foundation
GOG Foundation
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
NYU Langone Health
Dana-Farber Cancer Institute